Directory of guidance on prevention and control of Meticillin-resistant Staphylococcus aureus (MRSA), published by ECDC, EU/EEA Member States, international and national agencies and professional societies
The conference addressed long-term effectiveness HIV of drugs, co-infections with tuberculosis or viral hepatitis and other co-morbidities, and most inequitable access to care across Europe
The 31st IUSTI (International Union Against Sexually Transmitted Infections) Europe Congress addressed the broad range of science and clinical practice in the field of sexually transmitted infections.
The main objective of the course was to strengthen capacity in EU Member States for control of healthcare-associated infections due to multidrug-resistant organisms (MDROs) in acute health care settings and to promote the broadest possible implementation of appropriate methods. A second objective was to achieve team building between colleagues with similar responsibilities in control of nosocomial spread of MDROs and to share training approaches, knowledge and best practices.
Treatment enables people with HIV infection to live a long, healthy and productive life. It also reduces their viral load significantly and this has been shown to be important in preventing onward transmission of HIV.
Almost every second person (47%) diagnosed in 2014 was a late presenter or with indication of advanced infection. This means that these individuals are only diagnosed when their immune system already starts to fail.